NYSE:EHC Encompass Health Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Encompass Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. $45.96 -10.09 (-18.00%) (As of 07/1/2022 12:27 PM ET) Add Compare Share Today's Range$44.43▼$46.4450-Day Range$53.98▼$68.8352-Week Range$53.03▼$85.75Volume25,516 shsAverage Volume852,683 shsMarket Capitalization$4.59 billionP/E Ratio11.75Dividend Yield1.97%Price Target$79.56 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive EHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter. Email Address EHC Stock Forecast (MarketRank)Overall MarketRank™3.36 out of 5 starsMedical Sector9th out of 1,429 stocksHospitals Industry1st out of 5 stocksAnalyst Opinion: 3.6Community Rank: 4.9Dividend Strength: 2.5Insider Behavior: 3.3Valuation: 2.5 5 -4 -3 -2 -1 - 3.6 Analyst's Opinion Consensus RatingEncompass Health has received a consensus rating of Buy. The company's average rating score is 3.11, and is based on 8 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $79.56, Encompass Health has a forecasted upside of 73.1% from its current price of $45.96.Amount of Analyst CoverageEncompass Health has only been the subject of 3 research reports in the past 90 days. Previous Next 4.9 Community Rank Outperform VotesEncompass Health has received 462 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEncompass Health has received 164 “underperform” votes. (Add your “underperform” vote.)Community SentimentEncompass Health has received 73.80% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Encompass Health and other stocks. Vote “Outperform” if you believe EHC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EHC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend YieldEncompass Health pays a meaningful dividend of 1.97%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthEncompass Health does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Encompass Health is 28.64%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Encompass Health will have a dividend payout ratio of 24.72% next year. This indicates that Encompass Health will be able to sustain or increase its dividend. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Encompass Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $66,480.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of Encompass Health is held by insiders.Percentage Held by Institutions91.70% of the stock of Encompass Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Encompass Health are expected to grow by 10.76% in the coming year, from $4.09 to $4.53 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Encompass Health is 11.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 42.52.Price to Earnings Ratio vs. SectorThe P/E ratio of Encompass Health is 11.75, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 36.72.Price to Earnings Growth RatioEncompass Health has a PEG Ratio of 1.91. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioEncompass Health has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Encompass Health (NYSE:EHC)Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.Read More EHC Stock News HeadlinesJuly 1, 2022 | barrons.comPremarket Movers: INVESCO, Snap-On, Encompass HealthJuly 1, 2022 | finance.yahoo.comEncompass Health Corporation Completes Spin Off of Enhabit Home Health & HospiceJune 30, 2022 | americanbankingnews.comEncompass Health (NYSE:EHC) Rating Lowered to C+ at TheStreetJune 30, 2022 | americanbankingnews.comTheStreet Lowers Encompass Health (NYSE:EHC) to C+June 23, 2022 | americanbankingnews.comTruist Financial Lowers Encompass Health (NYSE:EHC) Price Target to $75.00June 23, 2022 | americanbankingnews.comEncompass Health (NYSE:EHC) Shares Gap Down on Analyst DowngradeJune 22, 2022 | americanbankingnews.comEncompass Health (NYSE:EHC) PT Lowered to $74.00June 21, 2022 | finance.yahoo.comEncompass Health (EHC) Opens EHR-Backed Hospital in FloridaJune 18, 2022 | americanbankingnews.comEncompass Health (NYSE:EHC) Price Target Cut to $70.00 by Analysts at Raymond JamesJune 16, 2022 | finance.yahoo.comEncompass Health (EHC) Forms JV With NCH Healthcare in NaplesJune 16, 2022 | nasdaq.comEHC August 19th Options Begin TradingJune 16, 2022 | finance.yahoo.com10 Safe Stocks to Buy in 2022 According to Seth KlarmanJune 15, 2022 | nasdaq.comNotable Wednesday Option Activity: EHC, JBL, ULTASee More Headlines Industry, Sector and Symbol Stock ExchangeNYSE Industry Hospitals Sub-IndustryHealth Care Facilities SectorMedical Current SymbolNYSE:EHC CUSIP42192430 CIK785161 Webwww.healthsouth.com Phone(205) 967-7116Fax205-969-4719Employees43,400Year Founded1984Company Calendar Ex-Dividend for 4/18 Dividend3/31/2022Dividend Payable4/18/2022Last Earnings4/27/2022Today7/01/2022Ex-Dividend for 7/20 Dividend7/12/2022Dividend Payable7/20/2022Next Earnings (Estimated)7/26/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$79.56 High Stock Price Forecast$98.00 Low Stock Price Forecast$70.00 Forecasted Upside/Downside+73.1%Consensus RatingBuy Rating Score (0-4)3.11111111111111 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$3.909990 Trailing P/E Ratio11.75 Forward P/E Ratio11.24 P/E Growth1.91Net Income$412.20 million Net Margins7.51% Pretax Margin12.08% Return on Equity17.99% Return on Assets6.13% Debt Debt-to-Equity Ratio1.32 Current Ratio1.26 Quick Ratio1.26 Sales & Book Value Annual Sales$5.12 billion Price / Sales0.90 Cash Flow$5.54 per share Price / Cash Flow8.30 Book Value$23.69 per share Price / Book1.94Miscellaneous Outstanding Shares99,803,000Free Float97,108,000Market Cap$4.59 billion OptionableOptionable Beta0.96 Social Links Encompass Health Frequently Asked Questions Should I buy or sell Encompass Health stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Encompass Health stock. View analyst ratings for Encompass Health or view top-rated stocks. What is Encompass Health's stock price forecast for 2022? 9 analysts have issued twelve-month price targets for Encompass Health's stock. Their EHC stock forecasts range from $70.00 to $98.00. On average, they predict Encompass Health's stock price to reach $79.56 in the next year. This suggests a possible upside of 73.1% from the stock's current price. View analysts' price targets for Encompass Health or view top-rated stocks among Wall Street analysts. How has Encompass Health's stock performed in 2022? Encompass Health's stock was trading at $65.26 at the beginning of the year. Since then, EHC shares have decreased by 29.6% and is now trading at $45.96. View the best growth stocks for 2022 here. When is Encompass Health's next earnings date? Encompass Health is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022. View our earnings forecast for Encompass Health. How were Encompass Health's earnings last quarter? Encompass Health Co. (NYSE:EHC) posted its quarterly earnings results on Wednesday, April, 27th. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.32 billion. Encompass Health had a trailing twelve-month return on equity of 17.99% and a net margin of 7.51%. Encompass Health's quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.05 earnings per share. View Encompass Health's earnings history. How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health? Encompass Health declared a quarterly dividend on Thursday, May 5th. Investors of record on Wednesday, July 13th will be paid a dividend of $0.28 per share on Wednesday, July 20th. This represents a $1.12 annualized dividend and a yield of 2.44%. The ex-dividend date is Tuesday, July 12th. View Encompass Health's dividend history. Is Encompass Health a good dividend stock? Encompass Health(NYSE:EHC) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.97%. The dividend payout ratio of Encompass Health is 28.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Encompass Health will have a dividend payout ratio of 24.72% next year. This indicates that Encompass Health will be able to sustain or increase its dividend. View Encompass Health's dividend history. What guidance has Encompass Health issued on next quarter's earnings? Encompass Health updated its FY 2022 earnings guidance on Tuesday, June, 28th. The company provided earnings per share (EPS) guidance of $3.76-$4.05 for the period, compared to the consensus estimate of $4.12. The company issued revenue guidance of $5.33 billion-$5.42 billion, compared to the consensus revenue estimate of $5.46 billion. Who are Encompass Health's key executives? Encompass Health's management team includes the following people: Mr. Mark J. Tarr, CEO, Pres & Director (Age 60, Pay $3.04M)Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 60, Pay $1.65M)Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 57)Ms. Barbara Ann Jacobsmeyer, Chief Exec. Officer of Home Health & Hospice (Age 56)Ms. Elissa Joy Charbonneau, Chief Medical Officer (Age 62, Pay $676.46k) (LinkedIn Profile)Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 54) (LinkedIn Profile)Mr. Rusty Yeager, Chief Information Officer & Sr. VPMr. Mark Miller, Sr. VP of Investor Relations & Strategic PlanningMs. Dawn Rock, Chief Compliance OfficerMr. Anthony A. Hernandez, Chief HR Officer (Age 56) What is Mark Tarr's approval rating as Encompass Health's CEO? 231 employees have rated Encompass Health CEO Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among Encompass Health's employees. Who are some of Encompass Health's key competitors? Some companies that are related to Encompass Health include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), Acadia Healthcare (ACHC), Tenet Healthcare (THC), The Ensign Group (ENSG), Petco Health and Wellness (WOOF), Select Medical (SEM), U.S. Physical Therapy (USPH), National HealthCare (NHC), Brookdale Senior Living (BKD), Community Health Systems (CYH) and Five Star Senior Living (FVE). View all of EHC's competitors. What other stocks do shareholders of Encompass Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Salesforce (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD). What is Encompass Health's stock symbol? Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC." How do I buy shares of Encompass Health? Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Encompass Health's stock price today? One share of EHC stock can currently be purchased for approximately $45.96. How much money does Encompass Health make? Encompass Health (NYSE:EHC) has a market capitalization of $4.59 billion and generates $5.12 billion in revenue each year. The company earns $412.20 million in net income (profit) each year or $3.909990 on an earnings per share basis. How many employees does Encompass Health have? Encompass Health employs 43,400 workers across the globe. When was Encompass Health founded? Encompass Health was founded in 1984. How can I contact Encompass Health? Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The official website for Encompass Health is www.healthsouth.com. The company can be reached via phone at (205) 967-7116, via email at [email protected], or via fax at 205-969-4719. This page (NYSE:EHC) was last updated on 7/1/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
